Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
23.51
+0.24 (1.03%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $51.63 million as of October 2, 2026. Its market cap has increased by 30.51% in one year.
Market Cap
51.63M
Enterprise Value
49.00M
1-Year Change
30.51%
Ranking
Category
Stock Price
$23.51
ChartMarket Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $51.63M, a decrease of -60.16%. That is a compound annual growth rate of -17.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 51.63M | 28.68% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 53.56M |
| eXoZymes | 53.55M |
| ImageneBio | 52.22M |
| Edesa Biotech | 52.15M |
| Celularity | 51.92M |
| Elicio Therapeutics | 50.46M |
| Annovis Bio | 50.28M |
| Serina Therapeutics | 49.78M |